Images List Premium Download Classic

Allergy

Allergy-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
Benzazepine sulfonamide compounds
September 28, 2017 - N°20170275253

Wherein r4 or r5 is —so2—nr7r8 and r1 to r8 and y are as defined in the description and in the claims, as well as pharmaceutically acceptable salts thereof. These compounds are tlr agonists and may therefore be useful as medicaments for the treatment of diseases such as cancer, autoimmune diseases, inflammation, sepsis, allergy, asthma, graft ...
Composition for the prevention and/or treatment of allergy symptoms
Ntc S.r.l.
September 14, 2017 - N°20170258864

The present invention relates to a pharmaceutical composition or a food supplement composition and use thereof in the prevention and/or treatment of allergy symptoms, preferably allergic rhinitis and/or allergic conjunctivitis symptoms. In particular, the composition according to the invention comprises at least one slow release component comprising quercetin and at least one fast release component comprising an extract ...
Nasal stimulation for rhinitis, nasal congestion, and ocular allergies
Oculeve, Inc.
August 24, 2017 - N°20170239459

Described here are devices, systems, and methods for treating one or more conditions, such as allergic rhinitis, non-allergic rhinitis, nasal congestion, ocular allergy, and/or symptoms associated with these conditions, by providing stimulation to nasal or sinus tissue. In some variations, the handheld devices may have a stimulator body and a stimulator probe having one or more nasal insertion prongs, ...
Allergy Patent Pack
Download + patent application PDFs
Allergy Patent Applications
Download + Allergy-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Allergy-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Immune regulatory oligonucleotide (iro) compounds to modulate toll-like receptor based immune response
Idera Pharmaceuticals, Inc.
August 17, 2017 - N°20170233741

The invention provides novel immune regulatory oligonucleotides (iro) as antagonist of tlrs and methods of use thereof. These iros have unique sequences that inhibit or suppress tlr-mediated signaling in response to a tlr ligand or tlr agonist. The methods may have use in the prevention and treatment of cancer, an autoimmune disorder, airway inflammation, inflammatory disorders, infectious disease, skin disorders, ...
Antibody therapeutics that bind ctla4
Sorrento Therapeutics, Inc.
August 17, 2017 - N°20170233476

There is disclosed compositions and methods relating to or derived from anti-ctla4 antibodies. More specifically, there is disclosed fully human antibodies that bind ctla4, ctla4-antibody binding fragments and derivatives of such antibodies, and ctla4-binding polypeptides comprising such fragments. Further still, there is disclosed nucleic acids encoding such antibodies, antibody fragments and derivatives and polypeptides, cells comprising such polynucleotides, ...
An anti-cd45rc antibody for use as drug
UniversitÉ De Nantes
August 10, 2017 - N°20170226209

The invention relates to an isolated anti-cd45rc antibody for use in preventing or treating transplant rejection, autoimmune diseases, unwanted immune responses against proteins expressed in the course of gene therapy and/or therapeutic proteins, allergy as well as lymphoma or cancer which are associated with cd45rc+ cells. The invention relates to an isolated anti-cd45rc antibody for use ...
Allergy Patent Pack
Download + patent application PDFs
Allergy Patent Applications
Download + Allergy-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Allergy-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Novel allergen
Phadia Ab
August 03, 2017 - N°20170219602

The invention relates to a novel horse allergen consisting of a heterodimeric protein having a first peptide chain and a second peptide chain together having an overall sequence identity of at least 70% with the combined sequences of seq id no:3 and seq id no: 4, as well as a single chain protein having an overall sequence identity of at least 70%, such ...
Peptides, reagents and methods for detecting food allergy
Icahn School Of Medicine At Mount Sinai
August 03, 2017 - N°20170219578

Provided are peptide biomarkers for diagnosis of allergy, monitoring development of clinical tolerance in an allergic individual, and predicting whether an allergic subject is likely to develop clinical or natural tolerance over time. The invention also relates to diagnostic methods and diagnostic kits employing the peptide biomarkers.
Nutritional compositions containing dietary butyrate and uses thereof
Mead Johnson Nutrition Company
August 03, 2017 - N°20170215464

Provided are nutritional compositions including a component for stimulating butyrate production in the human gut and/or dietary butyrate. Further disclosed are methods of reducing allergic reaction and promoting tolerance to cow's milk allergy in a pediatric subject by providing said nutritional compositions to a target subject.
Application of green tea and its derivatives, composition for use therewith, veterinary pharmaceutical formulation and ...
Mead Johnson Nutrition Company
July 27, 2017 - N°20170209512

Use of a composition comprising the administration of crushed leaves of green tea in the treatment of type i allergy. The composition may especially be enriched with substances extracted from green tea, preferably catechin or a derivative thereof. The veterinary treatment of type i allergy, as in the treatment of sweet itch, is especially envisaged. A preferred embodiment comprises a ...
Allergy-inhibiting sea grape extract, its preparation method and application thereof
East Green Bio Corporation
July 27, 2017 - N°20170209507

Present invention relates to an allergy-inhibiting sea grape extract, its preparation method and thereof. The preparation method includes following steps: the sea grape is blended in distilled water in the weight ratio of 1:1˜20, mix thoroughly, stir at 20-100° c. For 30˜120 minutes. The fluid obtained after the first filtration is the sea grape extract. The sea ...
Prevention or treatment of food allergy in infants and toddlers
N.v. Nutricia
July 27, 2017 - N°20170209472

The invention pertains to the use of a non-digestible oligosaccharide in the manufacture of a composition for providing nutrition to an infant suffering from an increased risk of food allergy, preferably whey protein allergy; and/or reducing the risk of occurrence of or preventing whey protein allergy in an infant suffering from an increased risk of food allergy, particularly whey ...
An isolated interleukin-34 polypeptide for use in preventing transplant rejection and treating autoimmune diseases
UniversitÉ De Nantes
July 20, 2017 - N°20170202921

The invention relates to an isolated interleukin-34 (il-34) polypeptide for use in preventing or treating graft rejection, autoimmune disease, unwanted immune response against therapeutic proteins and allergy. The invention also provides an in vitro method for determining whether a patient is at risk of transplant rejection, autoimmune diseases, unwanted immune response against therapeutic proteins or allergies, comprising a step of ...
Allergy Patent Pack
Download + patent application PDFs
Allergy Patent Applications
Download + Allergy-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Allergy-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Dd1alpha receptor and uses thereof in immune disorders
The General Hospital Corporation
June 29, 2017 - N°20170184604

Described herein are methods and compositions for treatment of immune-related diseases or disorders by modulating dd1α activity, alone or in combination with modulation of pd-1 activity. In some embodiments, the methods and compositions described herein are directed to treatment of cancer and/or infections (e. G., bacterial infection, and/or fungal infection). In some embodiments, the methods and ...
Allergy service management portal
Allergy Solutions, Inc.
June 22, 2017 - N°20170177802

Aspects of the present disclosure involve systems, programs, and methods for an allergy management system (ams). In general, the ams provides a system through which a practitioner or other user may manage allergy-related care for one or more patients. In one embodiment, the ams includes an application executed on a computing device, such as a tablet or other type of ...
Compositions and methods relating to the treatment of diseases
Alfacyte Ltd
June 22, 2017 - N°20170174735

The present invention relates to compositions and methods for promoting the induction of a cell-mediated immune response (such as that mediated by th1 cells) and the suppression of a humoral or allergic immune response (such as that mediated by th2 and th17 cells). In particular, the invention relates to compositions and methods for preventing or treating allergy, such as food ...
Compositions and methods for modulation of rorgammat functions
Alfacyte Ltd
June 08, 2017 - N°20170159057

The present invention relates to expression of rorγt in cells and tissues and the effect of expression of this gene on proliferation of specific immune cells and in promotion of immune cell aggregates and in induction of il17 producing cells. Furthermore, the invention relates to methods and agents that may decrease function of the gene product (the ...
Idr peptide compositions and use thereof for treatment of th2-dysregulated inflammatory conditions
University Of Manitoba
June 08, 2017 - N°20170158745

A composition for treating or preventing a th2-dysregulated inflammatory condition wherein the composition comprises a therapeutically effective amount of one or more idr peptides. Use of idr peptides or a composition comprising idr peptides for treating or preventing a th2-dysregulated inflammatory condition. The th2-dysregulated inflammatory condition includes allergy or atopy, for example allergic asthma.
Synergistic nutritional compositions and uses thereof
Mead Johnson Nutrition Company
June 08, 2017 - N°20170157242

Provided are nutritional compositions comprising a combination of a probiotic, dietary butyrate and/or a component for stimulating butyrate production in the human gut. Further disclosed are methods of accelerating tolerance to cow's milk allergy in a pediatric subject by providing said nutritional compositions to a target subject.
Peptide for vaccine
Circassia Limited
June 08, 2017 - N°20170157226

The present invention relates to compositions comprising peptides for preventing or treating allergy to house dust mites, and in particular to optimal combinations of peptides for preventing or treating said allergy.
Mobile chamber apparatuses and related methods
Inflamax Research Inc.
June 08, 2017 - N°20170156961

A mobile chamber apparatus includes a support structure of inflatable support members, and a chamber assembly. The inflatable support members may include transverse and upright sections. The chamber assembly may include a top wall, a bottom wall, and one or more side walls. Connectors may detachably couple the support structure and the chamber assembly. Installed, the support structure supports the ...
Loading